Kelkheim i. Ts, Germany

Kathleen Hobohm

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Kelkheim i. Ts., DE (2020)
  • Kelkheim i. Ts, DE (2019 - 2022)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kathleen Hobohm

Introduction

Kathleen Hobohm is a prominent inventor based in Kelkheim i. Ts, Germany. She has made significant strides in the field of immunotherapy, particularly through her innovative patents. With a total of four patents to her name, Hobohm's work focuses on enhancing the effectiveness of T cell therapies.

Latest Patents

One of her latest patents is titled "Enhancing the effect of CAR-engineered T cells by means of nucleic acid vaccination." This invention addresses the treatment of diseases by targeting cells that express specific antigens on their surface. The method involves stimulating, priming, and expanding in vivo T cells that have been genetically modified to express a chimeric antigen receptor (CAR) targeted to an antigen. The process includes administering a nucleic acid encoding the antigen or its variant to the T cells. Another notable patent is related to "Claudin-6-specific immunoreceptors and T cell epitopes." This invention provides Claudin-6-specific immunoreceptors, including T cell receptors and artificial T cell receptors, which are valuable for immunotherapy applications.

Career Highlights

Hobohm has worked with leading companies in the biotechnology sector, including BioNTech Cell & Gene Therapies GmbH and Biotech Cell & Gene Therapies GmbH. Her contributions to these organizations have been instrumental in advancing the field of gene therapies and immunotherapy.

Collaborations

Throughout her career, Kathleen Hobohm has collaborated with notable figures in the industry, including Ugur Sahin and Petra Simon. These partnerships have further enhanced her research and development efforts in the field of immunotherapy.

Conclusion

Kathleen Hobohm's innovative work and patents have significantly impacted the field of immunotherapy. Her dedication to advancing T cell therapies showcases her commitment to improving treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…